Small RNAs/Functional Genomics
Support and Educational Content

In vivo delivery of aptamer–DsiRNA molecules targeting HIV-1

Zhou J, Neff CP, et al. (2013) Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridge. Mol Ther, 21(1):192–200.

In an attempt to overcome the limitations and drawbacks of combinatorial antiretroviral therapy, which is currently used to suppress viral replication in HIV patients, Zhou and colleagues have been investigating safe and effective delivery of therapeutic doses of siRNAs to target tissues. The researchers previously delivered anti-HIV small interfering RNAs (siRNAs) to cells by covalent conjugation to ap­tamers. This design required synthesizing a different DNA transcription template for each siRNA–aptamer construct. In this article, the researchers describe a modification to the aptamer–siRNA molecule that creates an aptamer–bridge construct and improves the utility of aptamers as siRNA delivery vehicles. The aptamer specific to HIV-1 gp120 (anti-gp120 aptamer) was synthesized with a 3’ 7-carbon linker, which was attached to a 16-nt, 2’-O-methyl/2-fluoro, GC-rich bridge sequence. The siRNA, a Dicer-substrate siRNA (DsiRNA), also included a bridge sequence that was the reverse complement of the aptamer bridge. The bridge sequences hybridize providing a means to connect the 2 molecules and to easily interchange distinct DsiRNAs. The researchers describe the use of this construct for effective in vivo delivery of a cocktail of DsiRNAs manufactured by IDT. The authors further demonstrate functional in vivo delivery of multiplexed DsiRNAs using the aptamer–bridge construct by showing knockdown of target mRNAs and potent inhibition of HIV-1 repli­cation, as well as prolonged complete suppression of HIV-1 viral loads after follow-up treatment.

siRNAs with increased potency

Use IDT DsiRNAs to engage the Dicer-processing/RISC-loading mechanisms and get increased silencing potency over traditional siRNAs.

Learn more ≫

Related Articles

RNAi and DsiRNA: Pathway, Mechanism, and Design

An overview of the RNA interference (RNAi) pathway, its applications, and design considerations for gene silencing experiments.

Read more ≫

Using Antisense Technologies to Modulate Noncoding RNA Function

Useful modifications and design considerations for effective antisense oligonucleotides.

Read more ≫

Small RNA Therapies for Cystic Fibrosis

DsiRNAs are used to develop a protocol for efficient small RNA delivery into airway epithelia to study of miRNA regulation of airway fluid and electrolyte transport.

Read more ≫

Using DsiRNA to Map Pain Pathways in the CNS

Canadian laboratory targets pain receptors for expression knock out via in vivo delivery of DsiRNA 27mer duplex RNAs into the mouse CNS.

Read more ≫

The Future of RNAi and Aptamer Technologies—An Interview with John Rossi

An interview with Dr John Rossi, whose research focuses on the biology and applications of eukaryotic small RNAs and, in particular, their therapeutic use in HIV/AIDS and cancer.

Read more ≫